{"organizations": [], "uuid": "9a9a8d3865abde713fda2fc825965df8d613603e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180420.html", "section_title": "Archive News &amp; Video for Friday, 20 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-therapix-biosciences-co-terminated/brief-therapix-biosciences-co-terminated-research-license-agreement-between-co-yissum-research-development-co-idUSFWN1RX0DM", "country": "US", "domain_rank": 408, "title": "BRIEF-Therapix Biosciences - Co Terminated Research & License Agreement Between Co, Yissum Research Development Co", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.43, "site_type": "news", "published": "2018-04-20T19:38:00.000+03:00", "replies_count": 0, "uuid": "9a9a8d3865abde713fda2fc825965df8d613603e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-therapix-biosciences-co-terminated/brief-therapix-biosciences-co-terminated-research-license-agreement-between-co-yissum-research-development-co-idUSFWN1RX0DM", "ord_in_thread": 0, "title": "BRIEF-Therapix Biosciences - Co Terminated Research & License Agreement Between Co, Yissum Research Development Co", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-therapix biosciences - co terminated research & license agreement between co", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "therapix biosciences ltd", "sentiment": "negative"}, {"name": "yissum research development co", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 20 (Reuters) - Therapix Biosciences Ltd:\n* THERAPIX BIOSCIENCES - ON MARCH 18, 2018 CO TERMINATED RESEARCH & LICENSE AGREEMENT BETWEEN CO, YISSUM RESEARCH DEVELOPMENT CO, DATED MARCH 30, 2017 Source text: ( bit.ly/2F372wh ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://bit.ly/2F372wh", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-20T19:38:00.000+03:00", "crawled": "2018-04-21T18:05:46.001+03:00", "highlightTitle": ""}